Medicines
Musculoskeletal and Joint Diseases
Drugs used in rheumatic diseases and gout
Sarilumab

Sarilumab

Musculoskeletal and Joint Diseases Drugs used in rheumatic diseases and gout BNF 1001030AD

Data updated October 2024 Download CSV

1items

Dispensed in October 2024

0items

Rolling 12 months

£912

Net ingredient cost · October 2024

Figure 1. Sarilumab: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to October 2024

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/sarilumab-1001030ad" width="100%" height="280" style="border:0" loading="lazy" title="Sarilumab: NHS prescribing in England — PharmaInsight"></iframe>
<p style="font-size:13px;margin-top:4px">Chart: <a href="https://pharmainsight.co.uk/medicines/sarilumab-1001030ad">PharmaInsight</a> · Data: NHSBSA Prescription Cost Analysis</p>

Free to reuse with the credit line above.

At a glance

Therapeutic class Drugs used in rheumatic diseases and gout
Presentations 1 shown
Average cost / item £912.25

What this is

Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Where Sarilumab is dispensed

The regions and dispensing practices with the highest Sarilumab volumes.

Top regions

NHS North Central London Integrated Care Board 1

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Sarilumab with

Other medicines in the same BNF section, by prescribing volume.

Sarilumab vs Allopurinol Sarilumab vs Naproxen Sarilumab vs Methotrexate Sarilumab vs Hydroxychloroquine sulfate Sarilumab vs Methylprednisolone acetate

Download this data

The monthly series for Sarilumab is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.